Morningstar Acciones

Smith & Nephew PLC SNN StarRatingValueLabel_5Mr. Lee Davidson, Head of Quantitative Research

Último Precio
23,92
Cambio del día
0,12|0,50%

a 17/04/2024
19:00:00 EDT | USD  Minimum 15 Minutes Delay.

Bid/OffersRango del DíaVolumen90d Ave VolCapitalización
23,69 - 24,3023,83 - 24,051.065.889970.29110,44Bil
Último Cierre52 Week RangeP/BeneficioDividendo %ISIN
23,8021,53 - 33,0939,533,15US83175M2052

Cotización Smith & Nephew

Mr. Lee Davidson, Head of Quantitative Research
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
Cuentas Financieras
202120222023
More...
Cuenta de Resultados
Ingresos5.212,005.215,005.549,00
Operating Income721,00450,00660,00
Resultado Neto524,00223,00263,00
Beneficio Básico por Acción1,200,510,60
Num Medio Acciones diluidas en circulación439437437
Balance
Activo Corriente4.424,003.856,004.030,00
Activos no corrientes6.496,006.110,005.957,00
Total Activo 10.920,009.966,009.987,00
Pasivo corriente2.131,001.715,002.271,00
Total Pasivo---
Total Equity5.568,005.259,005.217,00
Flujo de Caja
Flujo de caja operativo877,00468,00608,00
Inversiones de Capital-408,00-358,00-427,00
Flujo de Caja Libre469,00110,00181,00

En millones, excepto "EPS básico". Currency is USD.

Perfil de la compañía

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Sector

Atención sanitaria

Industria

Dispositivos Médicos

Estilo de acciones

Media-Mixto

Fin Ejercicio Fiscal

diciembre

Empleados

18.452
Datos destacados
More...
Precio/Beneficio 12 m39,40
Precio/Valor contable1,99
Price/Sales TTM1,87
Crec Ingresos (media 3 a)6,76
Crec BPA (media 3 a)-
Margen operativo11,89
Margen neto4,74
ROE 12 m5,02
Deuda/Fondos propios0,44
Dividendos
AntLatest
Declared Date03/08/2304/03/24
Ex-Div05/10/2301/04/24
Paid01/11/2322/05/24
Amnt0,290,46
Mr. Lee Davidson, Head of Quantitative Research
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
© Copyright 2024 Morningstar, Inc. Reservados todos los derechos.

Términos de uso        Política Privacidad        Cookie Settings        Aviso Legal